GSK Stock Today: January 14 — Shingles Vaccine Market Seen at $3.56B by 2032
GSK stock: shingles vaccine market set to reach $3.56B by 2032 (8.36% CAGR). Japan vaccine subsidy timing and U.S. tariff risks may sway demand and margins. Valuation and technicals for JP investors.